UroGen Pharma Ltd. (URGN) dropped -5.47% or -2.59 to $44.75. It is nearly 97056 shares traded, which is 84.05% compare to the average total volume 115469. The market cap of URGN is $692.46 million. The year to date change is 17.04%. The 52 week price range is from $17.07 to $69.57. Price of URGN have changed -1.37% during last week. It have changed -8.34% over last month, -17.61% over last 3 months, -3.58% over last 6 months and 153.16% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for URGN is 55.59. It is 24.22% above current price. The 200-day Moving Averages for URGN is 48.09. It is 7.46% above current price. The 52-week High is 69.57. It is 55.46% from the current price. The 52-week Low is 17.07. It is -61.85% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of URGN is 0.73 on 2018-06-29. Short % to float is 0.70%. There are some statistics of URGN. It is has market cap $692.46 million. The share outstanding is 15.47 million. The average volume is 115469. The revenue is 7.81M. The gross profit is 7.52M. The percent of top 15 Institution holding is 57.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of URGN is -24.37%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of URGN is -23.33%.